[Intrathecal use of amikacin and colistin].
Hachimi
A
A
Charra
B
B
Benslama
A
A
Motaouakkil
S
S
D000151:Acinetobacter Infections / Q000150:complications / Q000188:drug therapy*; D040981:Acinetobacter baumannii / Q000187:drug effects* / Q000302:isolation & purification; D000368:Aged; D000583:Amikacin / Q000008:administration & dosage* / Q000627:therapeutic use; D002545:Brain Ischemia / Q000150:complications; D003091:Colistin / Q000008:administration & dosage* / Q000627:therapeutic use; D003428:Cross Infection / Q000188:drug therapy* / Q000382:microbiology; D024901:Drug Resistance, Multiple, Bacterial; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D006801:Humans; D006849:Hydrocephalus / Q000209:etiology / Q000601:surgery*; D007278:Injections, Spinal; D008297:Male; D016920:Meningitis, Bacterial / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D011552:Pseudomonas Infections / Q000150:complications; D012772:Shock, Septic / Q000150:complications; D013530:Surgical Wound Infection / Q000188:drug therapy* / Q000382:microbiology; D014696:Ventriculostomy
D000583:Amikacin; D003091:Colistin